>
pdufa.bio

ANB033

Updated ยทnext FDA decision on the calendar

ANB033 is a First Tracks Biotherapeutics, Inc. program. Its next catalyst is a Readout in Q4 2026. Every date links its source.

TRAX catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: First Tracks Biotherapeutics, Inc. (TRAX). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Q4 2026TRAX

Questions

When is ANB033's next FDA decision or readout?

The next tracked catalyst for ANB033 is a Readout in Q4 2026.

What happened at ANB033's most recent FDA decision?

No FDA decision for ANB033 is in our archive yet.

Who makes ANB033?

First Tracks Biotherapeutics, Inc. (TRAX).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.